Narrow Margin
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC (NCT07186621) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-07-10 |
| A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma (NCT07063888) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-05-16 |
| Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC. (NCT06205472) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-01-26 |
| Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study (NCT05602974) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-03-01 |
Track Narrow Margin automatically
Every clearance here is in the API, with alerts when new ones post.